Trademark: 86837302
Word
RENVIVO
Status
Dead
Status Code
606
Status Date
Monday, March 20, 2017
Serial Number
86837302
Mark Type
4000
Filing Date
Wednesday, December 2, 2015
Published for Opposition
Tuesday, June 21, 2016
Abandoned Date
Monday, March 20, 2017

Trademark Owner History

Classifications
1 Reagents, namely, a solution used for scientific and medical research purposes for handling of mammalian cells which keeps cells disaggregated, round and stopped in a stabile state while stabilizing membranes, membrane markers, membrane receptors and cluster differentiation (CD) markers; eukaryotic cell culture reagents, namely, a solution that contains enzymes for detaching and disassociating attached mammalian cell culture from the growth substrates for scientific research use or medical research use; Chemical preparations for scientific and medical research use, namely, sterile solutions that keeps dissociated eukaryotic cells round and unattached for long periods of time and blocks attachment to plastic surfaces for scientific and medical research purposes; chemical preparations for scientific and medical laboratory use, namely, a chemical solution for increasing recombinant protein or monoclonal antibody production from cultures of mammalian cells, except for medical or veterinary use
5 Organ preservation solutions for medical transplant use, namely, storage and preservation solution for machine perfusion of animal and human organs, tissues, and cells, specifically kidneys, abdominal organs and tissues, thoracic organs and tissues, and stem cells, for the purpose of transplantation; Nutrient-based solutions for medical use to store and treat cells, tissues, and organs in order to sustain life-providing systems, namely, solutions composed of complex mixtures of the nutrients required to support the normal cellular biochemistry and physiology, ex-vivo or in vitro, of living cells, tissues, and organs while preventing or slowing their death; Organ preservation solutions for medical transplant use, namely, a static, hypothermic, flushing, transport, and storage solution for animal and human organs, tissues, and cells, specifically whole hearts, heart tissue, cardiomyocytes, and stem cells, for the purpose of transplantation; Organ preservation solutions for medical transplant use, namely, storage and preservation solution for donor animal tissues and organs for the purpose of transplantation and for use in long-term mesothermic machine perfusion and ex-vivo healing and repair of tissues and organs; cell culture media for medical and veterinary use, namely, protein-free media for growing cells in biomedical and mammalian cell culture applications; Nutrient-based solutions for medical use in applications which require the support of life-providing systems in cells, tissues and organs, namely, solutions composed of complex mixtures of the nutrients required to support the normal cellular biochemistry and physiology, ex-vivo or in vitro, of living cells, tissues and organs while preventing or slowing their death; Nutritive substances for microorganism cultures for medical use, namely, a production boosting chemical solution for increasing recombinant protein or monoclonal antibody production from cultures of mammalian cells; Medical transplant solutions, namely, cornea preservation solutions used to aid in the flushing, transporting, storing, and preserving of animal corneas, eye tissues, eye cells, and stem cells for medical transplants
The wording "RENVIVO" has no meaning in a foreign language.

Trademark Events
Mar 20, 2017
Abandonment Notice Mailed - No Use Statement Filed
Mar 20, 2017
Abandonment - No Use Statement Filed
Aug 16, 2016
Noa E-Mailed - Sou Required From Applicant
Jun 21, 2016
Official Gazette Publication Confirmation E-Mailed
Jun 21, 2016
Published For Opposition
Jun 1, 2016
Notification Of Notice Of Publication E-Mailed
May 16, 2016
Law Office Publication Review Completed
May 6, 2016
Approved For Pub - Principal Register
May 6, 2016
Examiner's Amendment Entered
May 6, 2016
Notification Of Examiners Amendment E-Mailed
May 6, 2016
Examiners Amendment E-Mailed
May 6, 2016
Examiners Amendment -Written
Apr 18, 2016
Teas/Email Correspondence Entered
Apr 18, 2016
Correspondence Received In Law Office
Apr 8, 2016
Assigned To Lie
Mar 28, 2016
Teas Response To Office Action Received
Mar 23, 2016
Notification Of Non-Final Action E-Mailed
Mar 23, 2016
Non-Final Action E-Mailed
Mar 23, 2016
Non-Final Action Written
Mar 21, 2016
Assigned To Examiner
Dec 8, 2015
New Application Office Supplied Data Entered In Tram
Dec 5, 2015
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24